NewLimit, Inc. — Form D/A
NewLimit, Inc. of South San Francisco, CA, a company, filed a Form D amendment with the SEC on 2025-01-07. The offering totals $72.2M, of which $72.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-01-07
- Form: D/A
- Accession: 0001977037-25-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $72.2M
- Amount sold: $72.2M
- Investors: 21
- Date of first sale: 2023-05-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-481990
Issuer
- Name: NewLimit, Inc.
- CIK: 0001977037
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 901 Gateway Boulevard, South San Francisco, CA, 94080
- Phone: 415-603-9539
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Michael Polansky | Executive Officer | San Francisco, CA |
| Blake Byers | Director | Menlo Park, CA |
| Brian Armstrong | Director | South San Francisco, CA |
| Zavain Dar | Director | San Francisco, CA |
| Jacob Kimmel | Director | South San Francisco, CA |
| Jacob Kimmel | Executive Officer | South San Francisco, CA |
Other filings by this issuer (2)
More